Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Safety”

240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 240 results

Testing effectiveness (Phase 2)Ended earlyNCT05263492
What this trial is testing

Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer

Who this might be right for
Endometrial CancerMismatch Repair-ProficientRecurrent Endometrial Cancer
Virginia Commonwealth University 4
Testing effectiveness (Phase 2)Study completedNCT02150213
What this trial is testing

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

Who this might be right for
Adrenocortical AdenomaEndometrial Stromal Sarcomas
Novartis Pharmaceuticals 59
Early research (Phase 1)Looking for participantsNCT06276491
What this trial is testing

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Who this might be right for
Ovarian CancerEndometrial CancerGerm Cell Tumor+2 more
Xencor, Inc. 212
Not applicableUnknownNCT04959396
What this trial is testing

IUB SEAD RED (Revolutionary Endometrial Ablation Device Study

Who this might be right for
Heavy Menstrual Bleeding
Ocon Medical Ltd. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068
What this trial is testing

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+10 more
AstraZeneca 702
Early research (Phase 1)Looking for participantsNCT06586957
What this trial is testing

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more
NiKang Therapeutics, Inc. 150
Early research (Phase 1)Looking for participantsNCT05410717
What this trial is testing

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
Stage IV Ovarian CancerTestis Cancer, RefractoryEndometrial Cancer Recurrent+1 more
Second Affiliated Hospital of Guangzhou Medical University 200
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Not applicableStudy completedNCT06681831
What this trial is testing

Single-Port Hysterectomy (R-SPH) Using the Da Vinci SP System in Low-Risk Endometrial Cancer

Who this might be right for
Endometrial Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 15
Early research (Phase 1)Study completedNCT02743637
What this trial is testing

A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors

Who this might be right for
Advanced MalignancyAdvanced Solid TumorsNeoplasm+1 more
SynDevRx, Inc. 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639219
What this trial is testing

T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations

Who this might be right for
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
AstraZeneca 102
Early research (Phase 1)Study completedNCT00920257
What this trial is testing

A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795

Who this might be right for
Cancer
GlaxoSmithKline 77
Post-approval studies (Phase 4)Not Yet RecruitingNCT06897527
What this trial is testing

Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

Who this might be right for
Neoplasms, Endometrial
GlaxoSmithKline 100
Early research (Phase 1)Looking for participantsNCT06552598
What this trial is testing

The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies

Who this might be right for
Cervical CancerGynecologic MalignanciesEndometrial Cancer
Tongji Hospital 97
Early research (Phase 1)Study completedNCT02977195
What this trial is testing

First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorEndometrial CarcinomaHormone Receptor Positive
Centre Leon Berard 70
Early research (Phase 1)Study completedNCT06846099
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903

Who this might be right for
Ovarian CancerCervical CancerEndometrial Cancer+2 more
Risen (Suzhou) Pharma Tech Co., Ltd. 69
Testing effectiveness (Phase 2)Looking for participantsNCT06943521
What this trial is testing

MT-4561 in Patients With Various Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more
Tanabe Pharma America, Inc. 27
Early research (Phase 1)Study completedNCT05712889
What this trial is testing

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 29
Early research (Phase 1)WithdrawnNCT05905341
What this trial is testing

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Who this might be right for
Breast CancerOvarian CancerLiposarcoma+3 more
Pfizer
Testing effectiveness (Phase 2)Looking for participantsNCT05797168
What this trial is testing

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Who this might be right for
Ovarian CancerLung AdenocarcinomaEndometrial Cancer
AstraZeneca 506
Load More Results